DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.

DENTSPLY SIRONA Inc.

Prevent Group is a family-owned business established in 1952, focused on providing innovative solutions across various sectors, including manufacturing, financial services, and healthcare. Self-described as having a global reach, it offers tailored solutions to meet diverse industry challenges.

Prevent Group

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

West Pharmaceutical Services, Inc.

Zimmer Biomet develops and provides medical technology solutions aimed at alleviating pain and improving the quality of life for people around the world. Self-described as committed to advancing healthcare through cutting-edge technology.

Zimmer Biomet

Dentsply Sirona provides dental products and technologies, including CAD/CAM systems, intraoral scanners, dental laboratory solutions, imaging systems, restorative materials, and equipment for implant dentistry. The company is self-described as being involved in digital dentistry and education.

Metric
Company Name	DENTSPLY SIRONA Inc.	Prevent Group	West Pharmaceutical Services, Inc.	Zimmer Biomet
Symbol	XRAY		WST
MSH ID	COM:DENTSPLYSIRONA	COM:PREVENTGROUP	COM:WESTPHARMA	EU:ZIMMERBIOMET
Market	STOCKS	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare	Commercial & Professional Services	Healthcare	Healthcare & Health Services
Industry	Medical - Instruments & Supplies	Manufacturing	Medical - Instruments & Supplies	Medical Devices
Country	US	DE	US	EU
Stage
Employee Count	15K	501	10.60K
Website	dentsplysirona.com	preventgroup.com	westpharma.com	zimmerbiomet.eu
LinkedIn		preventgroupinternational		zimmerbiomet
Founders

Metric
Market Cap	5.07B		23.41B
Enterprise Value
Monthly Web Traffic		512		24.68K
Web Traffic Growth				-0.01
Valuation
Raised Capital

Metric
Revenue	3.96B	2.95B
Revenue (LTM)
Revenue (NTM)
Gross Profit	2.09B	1.13B
EBITDA	638M	875.70M
Operating Income	295M	676M
Net Income	-132M	593.40M
EPS	-0.62	7.98
Diluted EPS	-0.62	7.88
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.53	0.38
Operating Profit Margin	-0.02	0.23
EBITDA Margin	0.16	0.30
Net Profit Margin	-0.02	0.20
Return on Equity	-0.03	0.21
Return on Assets	-0.01	0.16
Return on Capital Employed	-0.01	0.22

COM:DENTSPLYSIRONA

Dentsply Sirona

Last Close

18.64

22/11 21:00

Market Cap

5.07B

Beta: -

Volume Today

1.96M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-32.49	52.81
P/B Ratio	2.10	10.30
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	2.31	9.76
EV Multiple	10.43	34.90

Metric
Days Sales Outstanding	60.18	64.74
Days Payables Outstanding	51.55	44.24
Days Inventory Outstanding	121.21	87.15
Operating Cycle	214.15	150.56
Cash Conversion Cycle	154.91	104.66
Asset Turnover	0.56	0.82

Metric
Operating Cash Flow	377M	776.50M
Free Cash Flow	228M	414.50M
Cash Flow to Debt	0.25	3.31
Operating Cash Flow/Sales	0.14	0.26
Free Cash Flow Yield	0.03	0.01

Metric
Cash & Equivalents	334M	853.90M
Accounts Receivable	-58M	4M
Inventory	624M	434.70M
Goodwill	2.44B	108.50M
Debt to Capitalization	0.42	0.10
Debt to Assets	0.29	0.08
Current Ratio	1.57	3.70
Quick Ratio	0.97	2.03

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01	0.01
R&D to Revenue	0.05	0.02
SG&A to Revenue